OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch, Shmuel Shoham, Arturo Casadevall, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 6, pp. 2757-2765
Open Access | Times Cited: 818
Evan M. Bloch, Shmuel Shoham, Arturo Casadevall, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 6, pp. 2757-2765
Open Access | Times Cited: 818
Showing 1-25 of 818 citing articles:
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 1417
Yiska Weisblum, Fabian Schmidt, Fengwen Zhang, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 1417
Viral targets for vaccines against COVID-19
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1055
Lianpan Dai, George F. Gao
Nature reviews. Immunology (2020) Vol. 21, Iss. 2, pp. 73-82
Open Access | Times Cited: 1055
Protocol and Reagents for Pseudotyping Lentiviral Particles with SARS-CoV-2 Spike Protein for Neutralization Assays
Katharine H. D. Crawford, Rachel Eguia, Adam S. Dingens, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 513-513
Open Access | Times Cited: 803
Katharine H. D. Crawford, Rachel Eguia, Adam S. Dingens, et al.
Viruses (2020) Vol. 12, Iss. 5, pp. 513-513
Open Access | Times Cited: 803
COVID-19: Immunology and treatment options
Susanna Felsenstein, Jenny A. Herbert, Paul McNamara, et al.
Clinical Immunology (2020) Vol. 215, pp. 108448-108448
Open Access | Times Cited: 657
Susanna Felsenstein, Jenny A. Herbert, Paul McNamara, et al.
Clinical Immunology (2020) Vol. 215, pp. 108448-108448
Open Access | Times Cited: 657
An Update on Current Therapeutic Drugs Treating COVID-19
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
Renyi Wu, Lujing Wang, Hsiao‐Chen Dina Kuo, et al.
Current Pharmacology Reports (2020) Vol. 6, Iss. 3, pp. 56-70
Open Access | Times Cited: 600
Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses
Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 11
Open Access | Times Cited: 572
Fabian Schmidt, Yiska Weisblum, Frauke Muecksch, et al.
The Journal of Experimental Medicine (2020) Vol. 217, Iss. 11
Open Access | Times Cited: 572
Fear of COVID-19 scale: Psychometric characteristics, reliability and validity in the Israeli population
Dana Tzur Bitan, Ariella Grossman‐Giron, Yuval Bloch, et al.
Psychiatry Research (2020) Vol. 289, pp. 113100-113100
Open Access | Times Cited: 541
Dana Tzur Bitan, Ariella Grossman‐Giron, Yuval Bloch, et al.
Psychiatry Research (2020) Vol. 289, pp. 113100-113100
Open Access | Times Cited: 541
Cytokine storm induced by SARS-CoV-2
Peipei Song, Wei Li, Jianqin Xie, et al.
Clinica Chimica Acta (2020) Vol. 509, pp. 280-287
Open Access | Times Cited: 536
Peipei Song, Wei Li, Jianqin Xie, et al.
Clinica Chimica Acta (2020) Vol. 509, pp. 280-287
Open Access | Times Cited: 536
Rapid Generation of Neutralizing Antibody Responses in COVID-19 Patients
Mehul S. Suthar, Matthew G. Zimmerman, Robert C. Kauffman, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 3, pp. 100040-100040
Open Access | Times Cited: 522
Mehul S. Suthar, Matthew G. Zimmerman, Robert C. Kauffman, et al.
Cell Reports Medicine (2020) Vol. 1, Iss. 3, pp. 100040-100040
Open Access | Times Cited: 522
COVID-19 infection alters kynurenine and fatty acid metabolism, correlating with IL-6 levels and renal status
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 522
Tiffany Thomas, Davide Stefanoni, Julie A. Reisz, et al.
JCI Insight (2020) Vol. 5, Iss. 14
Open Access | Times Cited: 522
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 1015-1027
Open Access | Times Cited: 514
Michael J. Joyner, Rickey E. Carter, Jonathon W. Senefeld, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 11, pp. 1015-1027
Open Access | Times Cited: 514
Neutralizing nanobodies bind SARS-CoV-2 spike RBD and block interaction with ACE2
Jiandong Huo, Audrey Le Bas, Reinis R. Ruza, et al.
Nature Structural & Molecular Biology (2020) Vol. 27, Iss. 9, pp. 846-854
Open Access | Times Cited: 505
Jiandong Huo, Audrey Le Bas, Reinis R. Ruza, et al.
Nature Structural & Molecular Biology (2020) Vol. 27, Iss. 9, pp. 846-854
Open Access | Times Cited: 505
Convalescent plasma in Covid-19: Possible mechanisms of action
Manuel Rojas, Yhojan Rodríguez, Diana M. Monsalve, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102554-102554
Open Access | Times Cited: 493
Manuel Rojas, Yhojan Rodríguez, Diana M. Monsalve, et al.
Autoimmunity Reviews (2020) Vol. 19, Iss. 7, pp. 102554-102554
Open Access | Times Cited: 493
Distinct antibody responses to SARS-CoV-2 in children and adults across the COVID-19 clinical spectrum
Stuart P. Weisberg, Thomas J. Connors, Yun Zhu, et al.
Nature Immunology (2020) Vol. 22, Iss. 1, pp. 25-31
Open Access | Times Cited: 490
Stuart P. Weisberg, Thomas J. Connors, Yun Zhu, et al.
Nature Immunology (2020) Vol. 22, Iss. 1, pp. 25-31
Open Access | Times Cited: 490
Organ-specific manifestations of COVID-19 infection
Maria Gavriatopoulou, Eleni Korompoki, Despina Fotiou, et al.
Clinical and Experimental Medicine (2020) Vol. 20, Iss. 4, pp. 493-506
Open Access | Times Cited: 470
Maria Gavriatopoulou, Eleni Korompoki, Despina Fotiou, et al.
Clinical and Experimental Medicine (2020) Vol. 20, Iss. 4, pp. 493-506
Open Access | Times Cited: 470
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
Sabra L. Klein, Andrew Pekosz, Han-Sol Park, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 6141-6150
Open Access | Times Cited: 444
Sabra L. Klein, Andrew Pekosz, Han-Sol Park, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 11, pp. 6141-6150
Open Access | Times Cited: 444
Neutralizing Antibody and Soluble ACE2 Inhibition of a Replication-Competent VSV-SARS-CoV-2 and a Clinical Isolate of SARS-CoV-2
James Brett Case, Paul W. Rothlauf, Rita E. Chen, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 3, pp. 475-485.e5
Open Access | Times Cited: 435
James Brett Case, Paul W. Rothlauf, Rita E. Chen, et al.
Cell Host & Microbe (2020) Vol. 28, Iss. 3, pp. 475-485.e5
Open Access | Times Cited: 435
Safety Update
Michael J. Joyner, Katelyn A. Bruno, Stephen A. Klassen, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 9, pp. 1888-1897
Open Access | Times Cited: 394
Michael J. Joyner, Katelyn A. Bruno, Stephen A. Klassen, et al.
Mayo Clinic Proceedings (2020) Vol. 95, Iss. 9, pp. 1888-1897
Open Access | Times Cited: 394
Detection of COVID-19: A review of the current literature and future perspectives
Tianxing Ji, Zhenwei Liu, Guoqiang Wang, et al.
Biosensors and Bioelectronics (2020) Vol. 166, pp. 112455-112455
Open Access | Times Cited: 369
Tianxing Ji, Zhenwei Liu, Guoqiang Wang, et al.
Biosensors and Bioelectronics (2020) Vol. 166, pp. 112455-112455
Open Access | Times Cited: 369
The complement system in COVID-19: friend and foe?
Anuja Java, Anthony J. Apicelli, M. Kathryn Liszewski, et al.
JCI Insight (2020) Vol. 5, Iss. 15
Open Access | Times Cited: 359
Anuja Java, Anthony J. Apicelli, M. Kathryn Liszewski, et al.
JCI Insight (2020) Vol. 5, Iss. 15
Open Access | Times Cited: 359
Two X‐linked agammaglobulinemia patients develop pneumonia as COVID‐19 manifestation but recover
Annarosa Soresina, Daniele Moratto, Marco Chiarini, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. 5, pp. 565-569
Open Access | Times Cited: 337
Annarosa Soresina, Daniele Moratto, Marco Chiarini, et al.
Pediatric Allergy and Immunology (2020) Vol. 31, Iss. 5, pp. 565-569
Open Access | Times Cited: 337
Tools and Techniques for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/COVID-19 Detection
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 336
Seyed Hamid Safiabadi Tali, Jason J. LeBlanc, Zubi Sadiq, et al.
Clinical Microbiology Reviews (2021) Vol. 34, Iss. 3
Open Access | Times Cited: 336
The Role of Antibody Testing for SARS-CoV-2: Is There One?
Elitza S. Theel, Patricia Slev, Sarah Wheeler, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 8
Open Access | Times Cited: 335
Elitza S. Theel, Patricia Slev, Sarah Wheeler, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 8
Open Access | Times Cited: 335
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327
Vanessa Piechotta, Khai Li Chai, Sarah J Valk, et al.
Cochrane library (2020)
Open Access | Times Cited: 327
Emerging treatment strategies for COVID-19 infection
Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Eleni Korompoki, et al.
Clinical and Experimental Medicine (2020) Vol. 21, Iss. 2, pp. 167-179
Open Access | Times Cited: 317
Maria Gavriatopoulou, Ioannis Ntanasis‐Stathopoulos, Eleni Korompoki, et al.
Clinical and Experimental Medicine (2020) Vol. 21, Iss. 2, pp. 167-179
Open Access | Times Cited: 317
